Patients
Patients
Diabetes Care
Obesity and Weight Management
Haemophilia
Hormone Replacement Therapy
- Hormone Replacement Therapy
Growth Hormone Therapy
Disease Experience Expert Panel (DEEP)
- Disease Experience Expert Panel (DEEP)
- DEEP News: A partnership that benefits patients
R&D
R&D
Inside R&D
R&D partnerships
Disease areas
R&D pipeline
The R&D pipeline reflects our long-term commitment to driving change to defeat obesity, haemophilia, growth disorders and other serious chronic diseases

Scientific publications
Scientific articles authored by Novo Nordisk scientists
R&D facts and figures
Facts and figures specific to our Research & Development organisation
Sustainable business
Sustainable business
Access to care
Environmental responsibility
Responsible business practices
Integrated reporting
How we report our financial, social and environmental performance
Positions, principles and policies
What guides the way we do business
The Sustainable Development Goals
How we contribute to the Sustainable Development Goals
Careers
Careers
Join us
Professionals
Career programmes
- PhD and PostDocs
- Medical Doctors
Graduates, Students and Trainees
About Novo Nordisk

Media
Products
Investors
Partnering
Contact us

Novo Nordisk Worldwide

Home

/Investors

/Calendar

Investors

Calendar

Subscribe to company announcements and press releases

Type of event

Show

Upcoming events

Past Events

Date range:

-

Date	Type	Event	Location	Add to calendar	Material

h2 text

When

Where

Category

Add to Calendar

Name

*

Email

*

Company

*

Position

*

Phone number

Overview

Who we are

Novo Nordisk is a global healthcare company with 95 years of innovation and leadership in diabetes care. This heritage has given us experience and capabilities that also enable us to help people defeat obesity, haemophilia, growth disorders and other serious chronic diseases.

Headquartered in Denmark, Novo Nordisk employs approximately 42,100 people in 79 countries and markets its products in more than 170 countries.

Novo Nordisk websites

Novo Nordisk in the USA
Novo Nordisk in Denmark

Or choose:

Novo Nordisk Worldwide

Novo Nordisk Worldwide - global contact information

Addresses and global contacts

Important safety information about NovoPen Echo^® and NovoPen^® 5

Read more about the issue

Shareholder Information

Annual reporting

Annual Report 2017

Contact quick links

Contact customer services
in your country
Report a side effect
Report product complaints
Report falsified products
Report a concern to the Compliance Hotline
Media contact

© 2018 Novo Nordisk A/S Disclaimer/Privacy Sitemap